Physiomics Plc announce that it has been awarded its first contract with a new UK-based biotech client. The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.244 GBX | -4.31% | -4.31% | -22.25% |
01/06 | EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech | AN |
31/05 | Physiomics Chief Scientist Steps Down | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.25% | 22.41L | |
-2.26% | 13TCr | |
+19.45% | 7.75TCr | |
-13.39% | 3.92TCr | |
-6.76% | 2.86TCr | |
-16.35% | 1.54TCr | |
+4.37% | 1.4TCr | |
+9.92% | 1.04TCr | |
-17.82% | 424.57Cr | |
-37.26% | 380.9Cr |
- Stock Market
- Equities
- PYC Stock
- News Physiomics Plc
- Physiomics plc Wins Further Contract by Uk-Based Biotech Client